Online citations, reference lists, and bibliographies.
← Back to Search

Mesoporous γ-Iron Oxide Nanoparticles For Magnetically Triggered Release Of Doxorubicin And Hyperthermia Treatment.

F. Benyettou, Jaen Alonso Ocadiz Flores, Florent Ravaux, Rachid Rezgui, M. Jouiad, Samer Nehme, R. K. Parsapur, J. Olsen, P. Selvam, A. Trabolsi
Published 2016 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Mesoporous iron-oxide nanoparticles (mNPs) were prepared by using a modified nanocasting approach with mesoporous carbon as a hard template. mNPs were first loaded with doxorubicin (Dox), an anticancer drug, and then coated with the thermosensitive polymer Pluronic F108 to prevent the leakage of Dox molecules from the pores that would otherwise occur under physiological conditions. The Dox-loaded, Pluronic F108-coated system (Dox@F108-mNPs) was stable at room temperature and physiological pH and released its Dox cargo slowly under acidic conditions or in a sudden burst with magnetic heating. No significant toxicity was observed in vitro when Dox@F108-mNPs were incubated with noncancerous cells, a result consistent with the minimal internalization of the particles that occurs with normal cells. On the other hand, the drug-loaded particles significantly reduced the viability of cervical cancer cells (HeLa, IC50 =0.70 μm), wild-type ovarian cancer cells (A2780, IC50 =0.50 μm) and Dox-resistant ovarian cancer cells (A2780/AD, IC50 =0.53 μm). In addition, the treatment of HeLa cells with both Dox@F108-mNPs and subsequent alternating magnetic-field-induced hyperthermia was significantly more effective at reducing cell viability than either Dox or Dox@F108-mNP treatment alone. Thus, Dox@F108-mNPs constitute a novel soft/hard hybrid nanocarrier system that is highly stable under physiological conditions, temperature-responsive, and has chemo- and thermotherapeutic modes of action.
This paper references
10.4155/TDE.11.72
Nanoparticle-mediated hyperthermia in cancer therapy.
D. Chatterjee (2011)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.4155/ppa.13.79
Pharmaceutical and biomedical applications of lipid-based nanocarriers.
C. Carbone (2014)
10.1088/0022-3727/42/22/224003
Progress in functionalization of magnetic nanoparticles for applications in biomedicine
C. Berry (2009)
10.1016/j.nano.2011.05.016
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
S. Parveen (2012)
10.1039/c4cc03036b
Self-assembly and applications of poly(glycidyl methacrylate)s and their derivatives.
Qing-Lan Li (2014)
10.1002/jgm.237
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
P. Chollet (2002)
10.1016/j.nano.2011.12.010
Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring.
Frédéric Geinguenaud (2012)
10.1021/am5036225
Current Advances in Polymer-Based Nanotheranostics for Cancer Treatment and Diagnosis
Brian T. Luk (2014)
10.1088/0022-3727/42/22/224001
TOPICAL REVIEW: Progress in applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2009)
Magn
M. Gonzales-Weimuller (1950)
10.1002/smll.201200272
Doxorubicin-conjugated mesoporous magnetic colloidal nanocrystal clusters stabilized by polysaccharide as a smart anticancer drug vehicle.
Dian Li (2012)
10.1021/acs.chemrev.5b00346
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.
Nazila Kamaly (2016)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.1021/ja2060512
Container effect in nanocasting synthesis of mesoporous metal oxides.
Xiaohong Sun (2011)
10.1016/J.MATLET.2008.01.086
Cation alkyl polyglycoside for preparation of mesoporous silica and direct synthesis of mesoporous carbon
A. Kong (2008)
10.1002/ADFM.201504185
Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches.
Jing Huang (2016)
10.1021/acsami.5b04216
Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
Yuanhao Wu (2015)
10.2165/00003088-200342050-00002
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
10.3390/gels1020135
Magnetic Gel Composites for Hyperthermia Cancer Therapy
M. Häring (2015)
10.7150/thno.12843
Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy
Yu-Lin Su (2015)
10.1039/c4dt02934h
Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin.
Katja Dralle Mjos (2015)
10.3390/POLYM3031215
Thermoresponsive Polymers for Biomedical Applications
M. Ward (2011)
10.1016/J.JMMM.2008.12.017
Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia.
M. Gonzales-Weimuller (2009)
10.1007/S11743-011-1308-X
Effect of Hydrophobicity of PEO–PPO–PEO Block Copolymers on Micellization and Solubilization of a Model Drug Nimesulide
A. Parmar (2012)
10.1021/acsami.5b10534
pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Qing-Lan Li (2015)
10.1021/am4043596
An optical sensing strategy leading to in situ monitoring of the degradation of mesoporous magnetic supraparticles in cells.
Dian Li (2013)
10.7150/thno.9199
Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release
K. Hayashi (2014)
10.1038/ncomms3952
A general approach to crystalline and monomodal pore size mesoporous materials.
Altug S. Poyraz (2013)
10.1021/LA00005A011
Temperature Effects on Structural Properties of Pluronic P104 and F108 PEO-PPO-PEO Block Copolymer Solutions
P. Alexandridis (1995)
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
L. Gerweck (1996)
10.2217/nnm.09.66
Magnetically modulated nanosystems: a unique drug-delivery platform.
N. Barakat (2009)
10.1063/1.1841461
Structural and microstructural characterization of nanocrystalline silicon thin films obtained by radio-frequency magnetron sputtering
M. Morales (2005)
Surfactants Deterg
a A. Parmar (2012)
10.1016/j.phrs.2010.01.014
Magnetic nanoparticles and targeted drug delivering.
J. Chomoucka (2010)
10.1021/am100237p
High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
K. Hayashi (2010)
10.1021/JA0584774
Ordered mesoporous Fe2O3 with crystalline walls.
F. Jiao (2006)
10.1002/jps.21350
PEGylation as a tool for the biomedical engineering of surface modified microparticles.
Uta Wattendorf (2008)
10.1016/J.MICROMESO.2010.01.017
Soft-templating approach for the synthesis of high surface area and superparamagnetic mesoporous iron oxide materials
A. Mitra (2010)
10.1016/j.jconrel.2011.06.001
Targeted drug delivery to tumors: myths, reality and possibility.
Y. Bae (2011)
10.1016/J.MATLET.2007.07.015
Preparation of super paramagnetic crystalline mesoporous γ-Fe2O3 with high surface
A. Kong (2008)
10.1021/JA002261E
Synthesis of New, Nanoporous Carbon with Hexagonally Ordered Mesostructure
S. Jun (2000)
10.1016/S1748-0132(07)70084-1
Magnetic nanoparticles for drug delivery
M. Arruebo (2007)
10.1016/j.watres.2009.05.041
Synthesis of mesoporous magnetic gamma-Fe2O3 and its application to Cr(VI) removal from contaminated water.
P. Wang (2009)
10.1038/sj.bjc.6690134
The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells
L. Gerweck (1999)
10.1039/c5cs00243e
Molecular and supramolecular switches on mesoporous silica nanoparticles.
N. Song (2015)
10.1021/ar4001026
Core-shell-corona polymeric micelles as a versatile template for synthesis of inorganic hollow nanospheres.
M. Sasidharan (2014)
10.1080/10611860290007559
By-passing of P-glycoprotein Using Immunoliposomes
J. Huwyler (2002)
10.1021/acs.biomac.5b00940
Self-Healing and Thermoresponsive Dual-Cross-Linked Alginate Hydrogels Based on Supramolecular Inclusion Complexes.
Tianxin Miao (2015)
Microporous Mesoporous Mater
A. Mitra (2010)
10.1039/C4PY00041B
Stimuli-responsive biocompatible nanovalves based on β-cyclodextrin modified poly(glycidyl methacrylate)
Qing-Lan Li (2014)
10.1017/S088571560001335X
X-Ray Powder Data for an Industrial Maghemite ( γ -Fe 2 O 3 )
D. Schulz (1988)
10.1016/S0304-8853(10)80013-7
Biological systems in high magnetic field
A. Yamagishi (1990)
10.1021/la304836e
Encapsulation of hydrophobic drugs in Pluronic F127 micelles: effects of drug hydrophobicity, solution temperature, and pH.
R. Basak (2013)
10.1016/J.PNSC.2012.11.005
Platinum-supported mesoporous carbon (Pt/CMK-3) as anodic catalyst for direct methanol fuel cell applications: The effect of preparation and deposition methods
Balaiah Kuppan (2012)
10.1016/J.NANTOD.2008.10.011
Biomedical nanoparticle carriers with combined thermal and magnetic responses
Ting-Yu Liu (2009)
10.1007/s00894-008-0319-7
Mesoscopic simulation studies on micellar phases of Pluronic P103 solution
Shouhong Yang (2008)
10.1039/c4cc10413g
Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
Xi-Long Qiu (2015)
10.1016/j.biomaterials.2013.06.046
Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles.
Dian Li (2013)
10.1021/cm503304p
Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release
Qing-Lan Li (2014)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1039/C4CS00322E
Emerging translational research on magnetic nanoparticles for regenerative medicine.
Y. Gao (2015)
www.chemeurj.org 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 9 && These are not the final page numbers! Full Paper FULL PAPER & Nanotechnology
A. Kong (2008)
10.1039/c5nr04130a
Magnetic nanoparticle-conjugated polymeric micelles for combined hyperthermia and chemotherapy.
H. Kim (2015)
10.1088/1748-6041/4/2/022001
Stimuli-responsive polymers and their applications in drug delivery.
P. Bawa (2009)
10.1016/j.chemosphere.2009.04.067
A fluorescence quenching study of the interaction of Suwannee River fulvic acid with iron oxide nanoparticles.
A. Manciulea (2009)
10.1021/MA061366K
Environmental Responsiveness of Microgel Particles and Particle-Stabilized Emulsions
T. Ngai (2006)
10.1021/LA047367S
Amphiphilic hydrogel nanoparticles. Preparation, characterization, and preliminary assessment as new colloidal drug carriers.
Dimitris Missirlis (2005)
10.1039/C5RA22960J
Thermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following γ-Fe2O3 NPs internalization and magnetic field application
A. Hanini (2016)
10.1016/j.actbio.2012.09.023
In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging.
W-M Li (2013)
10.7150/thno.11544
Magnetic Nanoparticles in Cancer Theranostics
O. Gobbo (2015)
10.1016/j.biomaterials.2009.09.044
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
M. Morille (2010)
10.1039/C3RA47490A
Synthesis of porous iron oxide microspheres by a double hydrophilic block copolymer
B. P. Bastakoti (2014)
10.1016/J.MICROMESO.2013.11.020
Nanoassembles constructed from mesoporous silica nanoparticles and surface-coated multilayer polyelectrolytes for controlled drug delivery
Y. Sun (2014)



This paper is referenced by
Inorganic nanoparticles for applications in biomedical sciences
Bhuvaneswari Koneru (2016)
10.1038/s41598-020-62429-6
Combined chemo-magnetic field-photothermal breast cancer therapy based on porous magnetite nanospheres
Majid Sharifi (2020)
10.3390/MAGNETOCHEMISTRY5030045
Preparation and Application of Iron Oxide Nanoclusters
Angelo J. Antone (2019)
10.2147/IJN.S226254
Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy
Mona Khafaji (2019)
10.1016/J.CERAMINT.2017.03.030
Re-formation of metastable ε-Fe2O3 in post-annealing of Fe2O3/SiO2 nanostructure: Synthesis, computational particle shape analysis in micrographs and magnetic properties
Violeta Nikolić (2017)
10.1021/acsami.7b11423
Sequential Delivery of Doxorubicin and Zoledronic Acid to Breast Cancer Cells by CB[7]-Modified Iron Oxide Nanoparticles.
F. Benyettou (2017)
10.1016/j.nano.2020.102309
Nanoparticle delivery systems to combat drug resistance in ovarian cancer.
E. M. Miller (2020)
10.1101/328211
Practical bioinstrumentation developments for AC magnetic field-mediated magnetic nanoparticle heating applications
M. Subramanian (2018)
10.1038/s41598-018-21156-9
Host-guest complexes of imazalil with cucurbit[8]uril and β-cyclodextrin and their effect on plant pathogenic fungi
Naji Al-Dubaili (2018)
10.1007/s10934-017-0508-9
Contemporary mesoporous materials for drug delivery applications: a review
P. Singh (2017)
10.1016/J.MICROMESO.2017.07.053
Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy
Z. Tian (2018)
10.1016/j.addr.2018.10.004
Triggering antitumoural drug release and gene expression by magnetic hyperthermia
M. Moros (2019)
10.1016/j.talanta.2018.01.018
Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging.
Yang Shu (2018)
10.1080/07391102.2020.1751296
Nanoporous iron oxide nanoparticle: hydrothermal fabrication, human serum albumin interaction and potential antibacterial effects.
M. Mehrabi (2020)
10.1039/c9tb00989b
Nanoarchitectured peroxidase-mimetic nanozymes: mesoporous nanocrystalline α- or γ-iron oxide?
M. Masud (2019)
10.1039/C8TB02741B
Magnetic nanoarchitectures for cancer sensing, imaging and therapy.
N. Knežević (2019)
10.1021/acsami.7b06105
Magnetic Resonance Imaging-Guided Multi-Drug Chemotherapy and Photothermal Synergistic Therapy with pH and NIR-Stimulation Release.
J. Yang (2017)
10.1039/C7RA02693E
Selective growth inhibition of cancer cells with doxorubicin-loaded CB[7]-modified iron-oxide nanoparticles
F. Benyettou (2017)
10.1016/J.JDDST.2020.102094
Hollow micro and nanostructures for therapeutic and imaging applications
Emir Yasun (2020)
10.1038/s41598-019-46007-z
Preparation of iron oxide mesoporous magnetic microparticles as novel multidrug carriers for synergistic anticancer therapy and deep tumor penetration
Kheireddine El-Boubbou (2019)
10.1002/chem.202000216
Aqueous Synthesis of Triphenylphosphine-Modified Gold Nanoparticles for Synergistic In Vitro and In Vivo Photo-thermal Chemotherapy.
F. Benyettou (2020)
10.1002/CNMA.201800487
Enhanced peroxidase mimetic activity of porous iron oxide nanoflakes
S. Tanaka (2019)
10.1002/chem.201605246
Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.
Tina Škorjanc (2017)
10.1007/s00339-019-2480-5
Practical bioinstrumentation developments for AC magnetic field-mediated magnetic nanoparticle heating applications
M. Subramanian (2019)
Semantic Scholar Logo Some data provided by SemanticScholar